Supernus Pharmaceuticals ... (SUPN)
32.72
0.23 (0.71%)
At close: Apr 04, 2025, 3:59 PM
31.66
-3.24%
After-hours: Apr 04, 2025, 04:43 PM EDT
Supernus Pharmaceuticals Revenue
Supernus Pharmaceuticals reported an annual revenue of $661.82M, reflecting a 8.94% growth. For the quarter ending December 31, 2024, Supernus Pharmaceuticals generated $174.16M in revenue.
Revenue (ttm)
$661.82M
Revenue Growth
8.94%
Price / Sales Ratio
3.01
Revenue / Employee
$981.92K
Employees
674
Market Cap
1.83B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 661.82M | +8.94% |
| Dec 31, 2023 | 607.52M | -8.95% |
| Dec 31, 2022 | 667.24M | +15.09% |
| Dec 31, 2021 | 579.77M | +11.41% |
| Dec 31, 2020 | 520.4M | n/a |